Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hamada

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502S Sadahiro, T Tsuchiya, K Sasaki, et al.
Clinical Nephrology|January 11, 2008
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitorY Tomino, T Yamazaki, I Shou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2016
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)E Oki, A Murata, K Yoshida, et al.
British Journal of Cancer|January 13, 2017
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancerT Ioka, Y Komatsu, N Mizuno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2014
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancerY Yamada, K Higuchi, K Nishikawa, et al.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Nature|September 17, 2025
CRISPR activation for SCN2A-related neurodevelopmental disordersSerena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
Randomized phase III trial of treatment duration for oral uracil and tegafur plus leucovorin as adjuvant chemotherapy for patients with stage IIB/III colon cancer: final results of JFMC33-0502S Sadahiro, T Tsuchiya, K Sasaki, et al.
Clinical Nephrology|January 11, 2008
Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitorY Tomino, T Yamazaki, I Shou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2016
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC)E Oki, A Murata, K Yoshida, et al.
British Journal of Cancer|January 13, 2017
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancerT Ioka, Y Komatsu, N Mizuno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 16, 2014
Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancerY Yamada, K Higuchi, K Nishikawa, et al.
British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.
Nature|September 17, 2025
CRISPR activation for SCN2A-related neurodevelopmental disordersSerena Tamura, Andrew D Nelson, Perry W E Spratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trialsT Yoshino, J M Cleary, E Van Cutsem, et al.
Pageof 7